AllStar Health Brands Inc. reports company developments across health products, sports development, and brand partnerships. The company has described a business focused on nutritional supplements, over-the-counter remedies, and medications serving North American and European markets, while recent updates also emphasize sports-related initiatives through AllStar Global Brands.
Recurring ALST news includes the Be Your Best soccer training platform, AI and virtual-reality tools for player development, youth soccer academy programs, sponsorship activity, and exploratory sports facility projects. Company announcements also cover strategic discussions involving soccer assets, international expansion, and collaborations intended to connect health, sports, and entertainment initiatives.
AllStar Health Brands Inc. (OTC PINK:ALST) announced it is in discussions to acquire a revenue-generating company based in the Northeast US, specializing in health supplements targeting diabetes and weight management. These conditions are linked to heightened risks of Covid-19, making the acquisition strategically significant for AllStar's growth. The company aims to expand the distribution of these products across the US and potentially in other Americas. Additionally, AllStar is actively marketing Covid-19 rapid antibody tests and QuikLAB testing modules.
AllStar Health Brands Inc. (OTC PINK:ALST) has expanded its distribution partnership with TPT Global Tech to include Canada and the US, augmenting their existing agreement for Mexico and Latin America. This collaboration aims to enhance the availability of QuikLAB testing modules for Covid-19, capable of performing up to 50 tests per hour. With a shared commitment to providing rapid testing solutions, AllStar plans to offer FDA-approved antibody and PCR tests to facilitate quick results for better health management during the pandemic.
AllStar Health Brands Inc. (ALST) has entered into a distribution agreement with TPT Global Tech for Covid-19 rapid testing solutions across Mexico and Latin America. The partnership aims to provide QuikLAB testing modules capable of delivering results within hours, addressing rising infection rates in the region. This approach includes mobile testing that can adapt to various locations, enhancing accessibility. The collaboration is expected to ensure a steady supply chain for testing kits amidst increasing demand due to the pandemic.